 | • レポートコード：MRC309Z7860 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の凍結乾燥ヒト狂犬病ワクチン（Vero細胞）の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の凍結乾燥ヒト狂犬病ワクチン（Vero細胞）市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 凍結乾燥ヒト狂犬病ワクチン（Vero細胞）の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 凍結乾燥ヒト狂犬病ワクチン（Vero細胞）市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・単箱、中箱 用途別セグメント ・病院、診療所 主要な市場プレーヤー ・Sanofi Pasteur、Serum Institute of India Pvt.、Bavarian Nordic、Bharat Biotech、AIM Vaccine、Liaoning Yisheng Biopharma、Changchun Zhuoyi Biological、Changchun Lnstitute of Biological Products、Liaoning Chengda Biotechnology、Wuhan Institute of Biological Products、ShanDong Yidu Biotechnology、Hualan Biological Bacterin、Guangzhou Promise Biologics 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、凍結乾燥ヒト狂犬病ワクチン（Vero細胞）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な凍結乾燥ヒト狂犬病ワクチン（Vero細胞）メーカーの企業概要、2019年～2022年までの凍結乾燥ヒト狂犬病ワクチン（Vero細胞）の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な凍結乾燥ヒト狂犬病ワクチン（Vero細胞）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別凍結乾燥ヒト狂犬病ワクチン（Vero細胞）の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの凍結乾燥ヒト狂犬病ワクチン（Vero細胞）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での凍結乾燥ヒト狂犬病ワクチン（Vero細胞）市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および凍結乾燥ヒト狂犬病ワクチン（Vero細胞）の産業チェーンを掲載しています。 ・第14、15章では、凍結乾燥ヒト狂犬病ワクチン（Vero細胞）の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 凍結乾燥ヒト狂犬病ワクチン（Vero細胞）の概要 - 種類別分析（2018年vs2022年vs2029年）：単箱、中箱 - 用途別分析（2018年vs2022年vs2029年）：病院、診療所 - 世界の凍結乾燥ヒト狂犬病ワクチン（Vero細胞）市場規模・予測 - 世界の凍結乾燥ヒト狂犬病ワクチン（Vero細胞）生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Sanofi Pasteur、Serum Institute of India Pvt.、Bavarian Nordic、Bharat Biotech、AIM Vaccine、Liaoning Yisheng Biopharma、Changchun Zhuoyi Biological、Changchun Lnstitute of Biological Products、Liaoning Chengda Biotechnology、Wuhan Institute of Biological Products、ShanDong Yidu Biotechnology、Hualan Biological Bacterin、Guangzhou Promise Biologics ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：単箱、中箱 ・用途別分析2018年-2029年：病院、診療所 ・凍結乾燥ヒト狂犬病ワクチン（Vero細胞）の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・凍結乾燥ヒト狂犬病ワクチン（Vero細胞）のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・凍結乾燥ヒト狂犬病ワクチン（Vero細胞）のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・凍結乾燥ヒト狂犬病ワクチン（Vero細胞）の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・凍結乾燥ヒト狂犬病ワクチン（Vero細胞）の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Freeze-dried Human Rabies Vaccine (Vero Cells) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Freeze-dried Human Rabies Vaccine (Vero Cells) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Freeze-dried Human Rabies Vaccine (Vero Cells) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Freeze-dried Human Rabies Vaccine (Vero Cells) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Freeze-dried Human Rabies Vaccine (Vero Cells) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Freeze-dried Human Rabies Vaccine (Vero Cells) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Freeze-dried Human Rabies Vaccine (Vero Cells)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Freeze-dried Human Rabies Vaccine (Vero Cells) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, Serum Institute of India Pvt., Bavarian Nordic, Bharat Biotech and AIM Vaccine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Freeze-dried Human Rabies Vaccine (Vero Cells) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single Box
Middle Box
Market segment by Application
Hospital
Clinic
Major players covered
Sanofi Pasteur
Serum Institute of India Pvt.
Bavarian Nordic
Bharat Biotech
AIM Vaccine
Liaoning Yisheng Biopharma
Changchun Zhuoyi Biological
Changchun Lnstitute of Biological Products
Liaoning Chengda Biotechnology
Wuhan Institute of Biological Products
ShanDong Yidu Biotechnology
Hualan Biological Bacterin
Guangzhou Promise Biologics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Freeze-dried Human Rabies Vaccine (Vero Cells) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Freeze-dried Human Rabies Vaccine (Vero Cells), with price, sales, revenue and global market share of Freeze-dried Human Rabies Vaccine (Vero Cells) from 2018 to 2023.
Chapter 3, the Freeze-dried Human Rabies Vaccine (Vero Cells) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Freeze-dried Human Rabies Vaccine (Vero Cells) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Freeze-dried Human Rabies Vaccine (Vero Cells) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Freeze-dried Human Rabies Vaccine (Vero Cells).
Chapter 14 and 15, to describe Freeze-dried Human Rabies Vaccine (Vero Cells) sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Freeze-dried Human Rabies Vaccine (Vero Cells)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Single Box
1.3.3 Middle Box
1.4 Market Analysis by Application
1.4.1 Overview: Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size & Forecast
1.5.1 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity (2018-2029)
1.5.3 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.1.4 Sanofi Pasteur Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 Serum Institute of India Pvt.
2.2.1 Serum Institute of India Pvt. Details
2.2.2 Serum Institute of India Pvt. Major Business
2.2.3 Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.2.4 Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Serum Institute of India Pvt. Recent Developments/Updates
2.3 Bavarian Nordic
2.3.1 Bavarian Nordic Details
2.3.2 Bavarian Nordic Major Business
2.3.3 Bavarian Nordic Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.3.4 Bavarian Nordic Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bavarian Nordic Recent Developments/Updates
2.4 Bharat Biotech
2.4.1 Bharat Biotech Details
2.4.2 Bharat Biotech Major Business
2.4.3 Bharat Biotech Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.4.4 Bharat Biotech Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bharat Biotech Recent Developments/Updates
2.5 AIM Vaccine
2.5.1 AIM Vaccine Details
2.5.2 AIM Vaccine Major Business
2.5.3 AIM Vaccine Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.5.4 AIM Vaccine Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AIM Vaccine Recent Developments/Updates
2.6 Liaoning Yisheng Biopharma
2.6.1 Liaoning Yisheng Biopharma Details
2.6.2 Liaoning Yisheng Biopharma Major Business
2.6.3 Liaoning Yisheng Biopharma Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.6.4 Liaoning Yisheng Biopharma Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Liaoning Yisheng Biopharma Recent Developments/Updates
2.7 Changchun Zhuoyi Biological
2.7.1 Changchun Zhuoyi Biological Details
2.7.2 Changchun Zhuoyi Biological Major Business
2.7.3 Changchun Zhuoyi Biological Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.7.4 Changchun Zhuoyi Biological Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Changchun Zhuoyi Biological Recent Developments/Updates
2.8 Changchun Lnstitute of Biological Products
2.8.1 Changchun Lnstitute of Biological Products Details
2.8.2 Changchun Lnstitute of Biological Products Major Business
2.8.3 Changchun Lnstitute of Biological Products Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.8.4 Changchun Lnstitute of Biological Products Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Changchun Lnstitute of Biological Products Recent Developments/Updates
2.9 Liaoning Chengda Biotechnology
2.9.1 Liaoning Chengda Biotechnology Details
2.9.2 Liaoning Chengda Biotechnology Major Business
2.9.3 Liaoning Chengda Biotechnology Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.9.4 Liaoning Chengda Biotechnology Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Liaoning Chengda Biotechnology Recent Developments/Updates
2.10 Wuhan Institute of Biological Products
2.10.1 Wuhan Institute of Biological Products Details
2.10.2 Wuhan Institute of Biological Products Major Business
2.10.3 Wuhan Institute of Biological Products Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.10.4 Wuhan Institute of Biological Products Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Institute of Biological Products Recent Developments/Updates
2.11 ShanDong Yidu Biotechnology
2.11.1 ShanDong Yidu Biotechnology Details
2.11.2 ShanDong Yidu Biotechnology Major Business
2.11.3 ShanDong Yidu Biotechnology Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.11.4 ShanDong Yidu Biotechnology Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 ShanDong Yidu Biotechnology Recent Developments/Updates
2.12 Hualan Biological Bacterin
2.12.1 Hualan Biological Bacterin Details
2.12.2 Hualan Biological Bacterin Major Business
2.12.3 Hualan Biological Bacterin Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.12.4 Hualan Biological Bacterin Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hualan Biological Bacterin Recent Developments/Updates
2.13 Guangzhou Promise Biologics
2.13.1 Guangzhou Promise Biologics Details
2.13.2 Guangzhou Promise Biologics Major Business
2.13.3 Guangzhou Promise Biologics Freeze-dried Human Rabies Vaccine (Vero Cells) Product and Services
2.13.4 Guangzhou Promise Biologics Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Guangzhou Promise Biologics Recent Developments/Updates
3 Competitive Environment: Freeze-dried Human Rabies Vaccine (Vero Cells) by Manufacturer
3.1 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Revenue by Manufacturer (2018-2023)
3.3 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Freeze-dried Human Rabies Vaccine (Vero Cells) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Freeze-dried Human Rabies Vaccine (Vero Cells) Manufacturer Market Share in 2022
3.4.2 Top 6 Freeze-dried Human Rabies Vaccine (Vero Cells) Manufacturer Market Share in 2022
3.5 Freeze-dried Human Rabies Vaccine (Vero Cells) Market: Overall Company Footprint Analysis
3.5.1 Freeze-dried Human Rabies Vaccine (Vero Cells) Market: Region Footprint
3.5.2 Freeze-dried Human Rabies Vaccine (Vero Cells) Market: Company Product Type Footprint
3.5.3 Freeze-dried Human Rabies Vaccine (Vero Cells) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size by Region
4.1.1 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Region (2018-2029)
4.1.2 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Region (2018-2029)
4.1.3 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Region (2018-2029)
4.2 North America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029)
4.3 Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029)
4.4 Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029)
4.5 South America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029)
4.6 Middle East and Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2029)
5.2 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Type (2018-2029)
5.3 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2029)
6.2 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Application (2018-2029)
6.3 Global Freeze-dried Human Rabies Vaccine (Vero Cells) Average Price by Application (2018-2029)
7 North America
7.1 North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2029)
7.2 North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2029)
7.3 North America Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size by Country
7.3.1 North America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2018-2029)
7.3.2 North America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2029)
8.2 Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2029)
8.3 Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size by Country
8.3.1 Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2018-2029)
8.3.2 Europe Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size by Region
9.3.1 Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2029)
10.2 South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2029)
10.3 South America Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size by Country
10.3.1 South America Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2018-2029)
10.3.2 South America Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Market Size by Country
11.3.1 Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Freeze-dried Human Rabies Vaccine (Vero Cells) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Freeze-dried Human Rabies Vaccine (Vero Cells) Market Drivers
12.2 Freeze-dried Human Rabies Vaccine (Vero Cells) Market Restraints
12.3 Freeze-dried Human Rabies Vaccine (Vero Cells) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Freeze-dried Human Rabies Vaccine (Vero Cells) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Freeze-dried Human Rabies Vaccine (Vero Cells)
13.3 Freeze-dried Human Rabies Vaccine (Vero Cells) Production Process
13.4 Freeze-dried Human Rabies Vaccine (Vero Cells) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Freeze-dried Human Rabies Vaccine (Vero Cells) Typical Distributors
14.3 Freeze-dried Human Rabies Vaccine (Vero Cells) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
